Cholesterol 25-hydroxylation activity of CYP3A

Journal of Lipid Research

Volumn 52, Issue 8, 2011, Pages 1509-1516

  Honda, Akira ^a   Miyazaki, Teruo ^a   Ikegami, Tadashi ^a   Iwamoto, Junichi ^a   Maeda, Tomomi ^b   Hirayama, Takeshi ^a   Saito, Yoshifumi ^a   Teramoto, Tamio ^b   Matsuzaki, Yasushi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

25 hydroxycholesterol; 4 hydroxycholesterol; Cerebrotendinous xanthomatosis; Cholesterol 25 hydroxylase; CYP27A1; CYP3A4; CYP46A1; Oxysterols

Indexed keywords

16ALPHA CYANOPREGNENOLONE; 25 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; 4BETA HYDROXYCHOLESTEROL; 7ALPHA HYDROXYCHOLESTEROL; CHOLESTEROL DERIVATIVE; CYTOCHROME P450 3A4; HYDROXYCHOLESTEROL; TROLEANDOMYCIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; BIOACCUMULATION; CATALYSIS; CELL LEVEL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME REGULATION; GENE OVEREXPRESSION; HUMAN; HYDROXYLATION; LIPID ANALYSIS; LIVER CELL; METABOLIC REGULATION; MOUSE; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; GENE EXPRESSION; HEPATOCYTES; HUMANS; HYDROXYCHOLESTEROLS; LIPID METABOLISM; LIVER; MICE; POLYMERASE CHAIN REACTION; PREGNENOLONE CARBONITRILE; RNA, MESSENGER; STEROID HYDROXYLASES; TROLEANDOMYCIN;

EID: 79960671360     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M014084     Document Type: Article

References (37)

1. Gill, S., R. Chow, and A. J. Brown. 2008. Sterol regulators of cholesterol homeostasis and beyond: the oxysterol hypothesis revisited and revised. Prog. Lipid Res. 47: 391-404.
2. Krieger, M., J. L. Goldstein, and M. S. Brown. 1978. Receptor-mediated uptake of low density lipoprotein reconstituted with 25-hydroxycholesteryl oleate suppresses 3-hydroxy-3-methylglutaryl- coenzyme A reductase and inhibits growth of human fibroblasts. Proc. Natl. Acad. Sci. USA. 75: 5052-5056.
3. Spencer, T. A., A. K. Gayen, S. Phirwa, J. A. Nelson, F. R. Taylor, A. A. Kandutsch, and S. K. Erickson. 1985. 24(S),25-epoxycholesterol. Evidence consistent with a role in the regulation of hepatic cholesterogenesis. J. Biol. Chem. 260: 13391-13394.
4. Axelson, M., and O. Larsson. 1995. Low density lipoprotein (LDL) cholesterol is converted to 27-hydroxycholesterol in human fibroblasts. J. Biol. Chem. 270: 15102-15110.
5. Adams, C. M., J. Reitz, J. K. De Brabander, J. D. Feramisco, L. Li, M. S. Brown, and J. L. Goldstein. 2004. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J. Biol. Chem. 279: 52772-52780.
6. Radhakrishnan, A., Y. Ikeda, H. J. Kwon, M. S. Brown, and J. L. Goldstein. 2007. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc. Natl. Acad. Sci. USA. 104: 6511-6518.
7. Goldstein, J. L., R. A. DeBose-Boyd, and M. S. Brown. 2006. Protein sensors for membrane sterols. Cell. 124: 35-46.
8. Janowski, B. A., P. J. Willy, T. R. Devi, J. R. Falck, and D. J. Mangelsdorf. 1996. An oxysterol signalling pathway mediated by the nuclear receptor LXRα. Nature. 383: 728-731.
9. Janowski, B. A., M. J. Grogan, S. A. Jones, G. B. Wisely, S. A. Kliewer, E. J. Corey, and D. J. Mangelsdorf. 1999. Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ. Proc. Natl. Acad. Sci. USA. 96: 266-271.
10. Reschly, E. J., N. Ai, W. J. Welsh, S. Ekins, L. R. Hagey, and M. D. Krasowski. 2008. Ligand specificity and evolution of liver X receptors. J. Steroid Biochem. Mol. Biol. 110: 83-94.
11. Wojcicka, G., A. Jamroz-Wisniewska, K. Horoszewicz, and J. Beltowski. 2007. Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism. Postepy Hig. Med. Dosw. (Online). 61: 736-759.
12. Jamroz-Wisniewska, A., G. Wojcicka, K. Horoszewicz, and J. Beltowski. 2007. Liver X receptors (LXRs). Part II: non-lipid effects, role in pathology, and therapeutic implications. Postepy Hig. Med. Dosw. (Online). 61: 760-785.
13. Lund, E. G., T. A. Kerr, J. Sakai, W. P. Li, and D. W. Russell. 1998. cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J. Biol. Chem. 273: 34316-34327.
14. Bauman, D. R., A. D. Bitmansour, J. G. McDonald, B. M. Thompson, G. Liang, and D. W. Russell. 2009. 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production. Proc. Natl. Acad. Sci. USA. 106: 16764-16769.
15. Diczfalusy, U., K. E. Olofsson, A. M. Carlsson, M. Gong, D. T. Golenbock, O. Rooyackers, U. Flaring, and H. Bjorkbacka. 2009. Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J. Lipid Res. 50: 2258-2264.
16. Lund, E., I. Björkhem, C. Furster, and K. Wikvall. 1993. 24-, 25-and 27-hydroxylation of cholesterol by a purified preparation of 27-hydroxylase from pig liver. Biochim. Biophys. Acta. 1166: 177-182. (Pubitemid 23060891)
17. Li, X., W. M. Pandak, S. K. Erickson, Y. Ma, L. Yin, P. Hylemon, and S. Ren. 2007. Biosynthesis of the regulatory oxysterol, 5-cholesten- 3β,25-diol 3-sulfate, in hepatocytes. J. Lipid Res. 48: 2587-2596. (Pubitemid 350272843)
18. Lund, E. G., J. M. Guileyardo, and D. W. Russell. 1999. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. USA. 96: 7238-7243.
19. Smith, L. L. 1981. Cholesterol Autoxidation. Plenum Press, New York.
20. Honda, A., G. Salen, Y. Matsuzaki, A. K. Batta, G. Xu, E. Leitersdorf, G. S. Tint, S. K. Erickson, N. Tanaka, and S. Shefer. 2001. Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27-/- mice and CTX. J. Lipid Res. 42: 291-300. (Pubitemid 32206842)
21. Honda, A., G. Salen, Y. Matsuzaki, A. K. Batta, G. Xu, E. Leitersdorf, G. S. Tint, S. K. Erickson, N. Tanaka, and S. Shefer. 2001. Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27-/- mice but not in cerebrotendinous xanthomatosis. J. Biol. Chem. 276: 34579-34585.
22. Kliewer, S. A., and T. M. Willson. 2002. Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. J. Lipid Res. 43: 359-364.
23. Bodin, K., L. Bretillon, Y. Aden, L. Bertilsson, U. Broome, C. Einarsson, and U. Diczfalusy. 2001. Antiepileptic drugs increase plasma levels of 4β-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. J. Biol. Chem. 276: 38685-38689.
24. Diczfalusy, U., K. P. Kanebratt, E. Bredberg, T. B. Andersson, Y. Bottiger, and L. Bertilsson. 2008. 4β-Hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin. Br. J. Clin. Pharmacol. 67: 38-43.
25. Dzeletovic, S., O. Breuer, E. Lund, and U. Diczfalusy. 1995. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225: 73-80.
26. Wu, J. C., G. Merlino, and N. Fausto. 1994. Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor α. Proc. Natl. Acad. Sci. USA. 91: 674-678. (Pubitemid 24041464)
27. Honda, A., K. Yamashita, H. Miyazaki, M. Shirai, T. Ikegami, G. Xu, M. Numazawa, T. Hara, and Y. Matsuzaki. 2008. Highly sensitive analysis of sterol profiles in human serum by LC-ESI-MS/MS. J. Lipid Res. 49: 2063-2073.
28. Honda, A., K. Yamashita, T. Hara, T. Ikegami, T. Miyazaki, M. Shirai, G. Xu, M. Numazawa, and Y. Matsuzaki. 2009. Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. J. Lipid Res. 50: 350-357.
29. Honda, A., T. Miyazaki, T. Ikegami, J. Iwamoto, K. Yamashita, M. Numazawa, and Y. Matsuzaki. 2010. Highly sensitive and specific analysis of sterol profiles in biological samples by HPLC-ESI-MS/ MS. J. Steroid Biochem. Mol. Biol. 121: 556-564.
30. Ono, S., T. Hatanaka, H. Hotta, T. Satoh, F. J. Gonzalez, and M. Tsutsui. 1996. Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica. 26: 681-693. (Pubitemid 26233022)
31. Bodin, K., U. Andersson, E. Rystedt, E. Ellis, M. Norlin, I. Pikuleva, G. Eggertsen, I. Bjorkhem, and U. Diczfalusy. 2002. Metabolism of 4β-hydroxycholesterol in humans. J. Biol. Chem. 277: 31534-31540
32. Norlin, M., U. Andersson, I. Bjorkhem, and K. Wikvall. 2000. Oxysterol 7α-hydroxylase activity by cholesterol 7α-hydroxylase (CYP7A). J. Biol. Chem. 275: 34046-34053.
33. Li-Hawkins, J., E. G. Lund, S. D. Turley, and D. W. Russell. 2000. Disruption of the oxysterol 7α-hydroxylase gene in mice. J. Biol. Chem. 275: 16536-16542.
34. Guengerich, F. P. 1990. Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene. Chem. Res. Toxicol. 3: 363-371. (Pubitemid 20322680)
35. Swell, L., C. C. Schwartz, J. Gustafsson, H. Danielsson, and Z. R. Vlahcevic. 1981. A quantitative evaluation of the conversion of 25-hydroxycholesterol to bile acids in man. Biochim. Biophys. Acta. 663: 163-168.
36. Repa, J. J., E. G. Lund, J. D. Horton, E. Leitersdorf, D. W. Russell, J. M. Dietschy, and S. D. Turley. 2000. Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. J. Biol. Chem. 275: 39685-39692.
37. Honda, A., G. Salen, Y. Matsuzaki, A. K. Batta, G. Xu, T. Hirayama, G. S. Tint, M. Doy, and S. Shefer. 2005. Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis. J. Lipid Res. 46: 287-296. (Pubitemid 40271093)